H2-O influence on antigen presentation in H2-E-expressing mice

被引:16
作者
Alfonso, C [1 ]
Williams, GS [1 ]
Karlsson, L [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev, San Diego, CA 92121 USA
关键词
MHC; antigen presentation/processing; H2-O;
D O I
10.1002/eji.200323853
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MHC class II molecules sample peptides generated in the endosomal/lysosomal system for cell surface presentation to CD4(+) T cells. Peptide loading requires the endosomal/lysosomal resident HLA-DM (DM; H2-DM, mouse), but in B cells, DM is tightly associated with HLA-DO (DO; H2-O, mouse). We have previously shown that H2-O differentially modulates the processing and presentation of different antigenic epitopes on H2-A(b) molecules. Using H2-Ea(d)-transgenic mice, we here show that presentation of different epitopes by H2-E-d/b molecules is similarly influenced by H2-O after membrane immunoglobulin-mediated uptake of antigen. In addition, B cells from H2-Ea(d)-transgenic mice (which co-express H2-A(b) and H2-E-d/b molecules) show an altered pattern of presentation of H2-A(b)-restricted epitopes. In H2-Ea(d)-transgenic, H2-O-deficient mice, further changes in the peptide repertoire were observed. Thus, H2-E-d/b expression influences the epitopes presented by H2-A(b), and this effect is further altered by expression of H2-O.
引用
收藏
页码:2014 / 2021
页数:8
相关论文
共 27 条
[1]   The impact of H2-DM on humoral immune responses [J].
Alfonso, C ;
Han, JO ;
Williams, GS ;
Karlsson, L .
JOURNAL OF IMMUNOLOGY, 2001, 167 (11) :6348-6355
[2]   Nonclassical MHC class II molecules [J].
Alfonso, C ;
Karlsson, L .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :113-+
[3]   Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes [J].
Brocke, P ;
Armandola, E ;
Garbi, N ;
Hämmerling, GJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (02) :411-421
[4]   Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development [J].
Chen, XJ ;
Laur, O ;
Kambayashi, T ;
Li, SY ;
Bray, RA ;
Weber, DA ;
Karlsson, L ;
Jensen, PE .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (08) :1053-1062
[5]   DETERMINANT CAPTURE AS A POSSIBLE MECHANISM OF PROTECTION AFFORDED BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES IN AUTOIMMUNE-DISEASE [J].
DENG, HK ;
APPLE, R ;
CLARESALZLER, M ;
TREMBLEAU, S ;
MATHIS, D ;
ADORINI, L ;
SERCARZ, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1675-1680
[6]   Negative regulation by HLA-DO of MHC class II-restricted antigen processing [J].
Denzin, LK ;
SantAngelo, DB ;
Hammond, C ;
Surman, MJ ;
Cresswell, P .
SCIENCE, 1997, 278 (5335) :106-109
[7]   Antigen presentation and T cell development in H2-M-deficient mice [J].
FungLeung, WP ;
Surh, CD ;
Liljedahl, M ;
Pang, J ;
Leturcq, D ;
Peterson, PA ;
Webb, SR ;
Karlsson, L .
SCIENCE, 1996, 271 (5253) :1278-1281
[8]   IGG ANTIBODIES TO PHOSPHORYLCHOLINE EXHIBIT MORE DIVERSITY THAN THEIR IGM COUNTERPARTS [J].
GEARHART, PJ ;
JOHNSON, ND ;
DOUGLAS, R ;
HOOD, L .
NATURE, 1981, 291 (5810) :29-34
[9]   HETEROGENEITY OF BALB/C ANTIPHOSPHORYLCHOLINE ANTIBODY-RESPONSE AT PRECURSOR CELL LEVEL [J].
GEARHART, PJ ;
SIGAL, NH ;
KLINMAN, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 141 (01) :56-71
[10]   Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO [J].
Glazier, KS ;
Hake, SB ;
Tobin, HM ;
Chadburn, A ;
Schattner, EJ ;
Denzin, LK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (08) :1063-1069